• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素绵羊受体激动剂的药效团搜索及3D-QSAR比较分子场分析研究

Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.

作者信息

Marot C, Chavatte P, Morin-Allory L, Viaud M C, Guillaumet G, Renard P, Lesieur D, Michel A

机构信息

Institut de Chimie Organique et Analytique, associé au CNRS, Université d'Orléans, BP 6759, 45067 Orléans Cedex 2, France.

出版信息

J Med Chem. 1998 Nov 5;41(23):4453-65. doi: 10.1021/jm980026p.

DOI:10.1021/jm980026p
PMID:9804685
Abstract

Conformational analysis was used to characterize the agonist pharmacophore for melatonin sheep brain receptor recognition and activation. The molecular geometry shared by all conformations of the selected active ligands was determined. Assuming that all the compounds interact at the same binding site at the receptor level, 2-iodomelatonin pharmacophoric conformation served as a template for the superimposition of 64 structurally heterogeneous agonists constituting the training set used to perform a three-dimensional quantitative structure-activity relationship study via the comparative molecular field analysis method. A statistically significant model was obtained for the totality of the compounds (n = 64, q2 = 0.62, N = 6, r2 = 0.96, s = 0.28, F = 249) with steric, electrostatic, and lipophilic relative contributions of 28%, 35%, and 37%, respectively. The predictive power of the proposed model was discerned by successfully testing the 78 agonist ligands constituting the test set. The model so obtained and validated brings important structural insights to aid the design of novel melatoninergic agonist ligands prior to their synthesis.

摘要

构象分析用于表征褪黑素绵羊脑受体识别和激活的激动剂药效团。确定了所选活性配体所有构象共有的分子几何结构。假设所有化合物在受体水平的同一结合位点相互作用,2-碘褪黑素的药效团构象用作叠加64种结构异质激动剂的模板,这些激动剂构成了用于通过比较分子场分析方法进行三维定量构效关系研究的训练集。对于所有化合物(n = 64,q2 = 0.62,N = 6,r2 = 0.96,s = 0.28,F = 249)获得了一个具有统计学意义的模型,其空间、静电和脂溶性相对贡献分别为28%、35%和37%。通过成功测试构成测试集的78种激动剂配体,识别了所提出模型的预测能力。如此获得并验证的模型为新型褪黑素能激动剂配体的合成前设计提供了重要的结构见解。

相似文献

1
Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.褪黑素绵羊受体激动剂的药效团搜索及3D-QSAR比较分子场分析研究
J Med Chem. 1998 Nov 5;41(23):4453-65. doi: 10.1021/jm980026p.
2
Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.褪黑素受体配体:新型褪黑素衍生物的合成及比较分子力场分析(CoMFA)综合研究
J Med Chem. 1998 Sep 24;41(20):3831-44. doi: 10.1021/jm9810093.
3
Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis study.褪黑素受体配体的三维定量构效关系:一项比较分子场分析研究
J Med Chem. 1997 Feb 28;40(5):739-48. doi: 10.1021/jm960680+.
4
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.对选定的MT1和MT2褪黑素受体配体的三维定量构效关系研究:亚型选择性和内在活性调节的要求
J Med Chem. 2003 Apr 10;46(8):1429-39. doi: 10.1021/jm020982d.
5
CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.基于比较分子力场分析(CoMFA)对重组D1和D2多巴胺受体激动剂亲和力的预测
J Med Chem. 1998 Oct 22;41(22):4385-99. doi: 10.1021/jm9800292.
6
Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.褪黑素受体的定位。5. 源自四氢环戊[b]吲哚、四氢咔唑和六氢环庚[b]吲哚的褪黑素激动剂和拮抗剂。
J Med Chem. 1998 Feb 12;41(4):451-67. doi: 10.1021/jm970246n.
7
3D QSAR comparative molecular field analysis on nonsteroidal farnesoid X receptor activators.非甾体类法尼醇X受体激活剂的3D QSAR比较分子场分析
J Mol Graph Model. 2007 Mar;25(6):921-7. doi: 10.1016/j.jmgm.2006.09.003. Epub 2006 Sep 14.
8
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.D1多巴胺受体激动剂的构象分析:药效团评估与受体图谱分析
J Med Chem. 1996 Jan 5;39(1):285-96. doi: 10.1021/jm9502100.
9
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.2-[N-酰基氨基(C1-C3)烷基]吲哚作为MT1褪黑素受体部分激动剂、拮抗剂和推定的反向激动剂。
J Med Chem. 1998 Sep 10;41(19):3624-34. doi: 10.1021/jm970721h.
10
Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.2-酰胺基-2,3-二氢-1H-菲衍生物的合成:作为褪黑素受体新型构象受限配体
J Med Chem. 1996 Aug 2;39(16):3089-95. doi: 10.1021/jm960219h.

引用本文的文献

1
Synthesis and Biological Evaluations of Granulatamide B and its Structural Analogues.格拉纳特酰胺 B 及其结构类似物的合成与生物学评价。
Curr Med Chem. 2024;31(25):3997-4021. doi: 10.2174/0109298673272687231226111132.
2
Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.新型阿戈美拉汀构象限制类似物作为新型褪黑素能配体。
Molecules. 2012 Dec 24;18(1):154-66. doi: 10.3390/molecules18010154.
3
New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.新型喹喔啉衍生物作为潜在的 MT₁ 和 MT₂ 受体配体。
Molecules. 2012 Jun 25;17(7):7737-57. doi: 10.3390/molecules17077737.